Back to Longevity
Longevity

Cancer ScreeningEvidence & Dosage

Recommendations, overdiagnosis, Galleri tests, whole-body MRI (a critical look).

Evidence at a glance

Total studies
1,000
With abstract
40
Meta / Systematic / RCT
1
Highly cited
5
Publication years
1961–2026

Cancer Screening in the context of Longevity

This topic is part of our "Longevity" world. There you'll find methodology, evidence and the highest-impact levers — plus the order in which they sensibly build on each other.

Go to Longevity

Top studies on Cancer Screening

Ranked by influential-citation count and publication year.

  1. Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline.

    J Clin Oncol2013n=19Systematic Review67 influential citations

    <h4>Purpose</h4>To update the 2009 American Society of Clinical Oncology guideline on pharmacologic interventions for breast cancer (BC) risk reduction.<h4>Methods</h4>A systematic review of randomized controlled trials and meta-analyses…

  2. Screening for cervical cancer: a systematic review and meta-analysis

    Systematic Reviews20135 influential citations

    <h4>Background</h4>The systematic review on which this paper is based provided evidence for the Canadian Task Force on Preventive Health Care to update their guideline regarding screening for cervical cancer. In this article we highlight…

  3. Breast Cancer Screening Patterns Following National Crises: Experience from a Lebanese Tertiary Center.

    Asian Pacific journal of cancer prevention : APJCP2026n=642

    <h4>Background</h4>Lebanon's recent compounded crises-including economic collapse, the COVID-19 pandemic, and the Beirut Port explosion-have disrupted healthcare access, including breast cancer (BC) screening. This study assesses adherence…

  4. Knowledge of Colorectal Cancer Risk and Cancer Screening, with Colorectal Cancer Screening Attendance: A Nationwide Study in Japan (INFORM Study, 2020).

    Asian Pacific journal of cancer prevention : APJCP2026

    <h4>Background</h4>Despite the availability of colorectal cancer (CRC) screening, participation rates in Japan remain low. Although knowledge about CRC has been identified as a predictor of screening uptake, data specific to the Japanese…

  5. Reduced lung-cancer mortality with low-dose computed tomographic screening.

    The New England journal of medicine2011n=100,000

    <h4>Background</h4>The aggressive and heterogeneous nature of lung cancer has thwarted efforts to reduce mortality from this cancer through the use of screening. The advent of low-dose helical computed tomography (CT) altered the landscape…

  6. Screening and Prostate-Cancer Mortality in a Randomized European Study

    New England Journal of Medicine2009n=1,410

    <h4>Background</h4>The European Randomized Study of Screening for Prostate Cancer was initiated in the early 1990s to evaluate the effect of screening with prostate-specific-antigen (PSA) testing on death rates from prostate…

  7. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial

    New England Journal of Medicine2020n=13

    <h4>Background</h4>There are limited data from randomized trials regarding whether volume-based, low-dose computed tomographic (CT) screening can reduce lung-cancer mortality among male former and current smokers.<h4>Methods</h4>A total of…

  8. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

    European Urology2016

    <h4>Objective</h4>To present a summary of the 2016 version of the European Association of Urology (EAU) - European Society for Radiotherapy & Oncology (ESTRO) - International Society of Geriatric Oncology (SIOG) Guidelines on screening,…

  9. Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood

    New England Journal of Medicine1993n=46

    <h4>Background</h4>Although tests for occult blood in the feces are widely used to screen for colorectal cancers, there is no conclusive evidence that they reduce mortality from this cause. We evaluated a fecal occult-blood test in a…

  10. Mortality Results from a Randomized Prostate-Cancer Screening Trial

    New England Journal of Medicine2009n=76,693

    <h4>Background</h4>The effect of screening with prostate-specific-antigen (PSA) testing and digital rectal examination on the rate of death from prostate cancer is unknown. This is the first report from the Prostate, Lung, Colorectal, and…

Frequently asked

Are there safety considerations for Cancer Screening?
• Adverse events were considered in the review. • Other selective ER modulators and other aromatase inhibitors are not recommended outside a clinical trial.

More topics in Longevity

Zone 2 Training

Low-intensity cardio — mitochondrial biogenesis, a longevity foundation.

Rapamycin

mTOR inhibition, longevity studies, off‑label dosing, and safety.

AMPK Activators

Berberine, alpha‑lipoic acid, energetic stress, and glucose modulation.

ApoB

A better cardiovascular risk metric than LDL-C — modern lipidology.

Autophagy

Cellular self-clearance — fasting, exercise, spermidine as triggers.

Berberin

Glucose, lipids, AMPK and GI tolerability data

Biological Age

GrimAge, PhenoAge, DunedinPACE — what epigenetic clocks measure.

Caloric Restriction

CR mimetics, lifespan research, and NHP studies.

Cellular Senescence

"Zombie cells," SASP, senolytic approaches.

Collagen

Skin, joints, tendons — evidence favors hydrolysate plus vitamin C.

Dementia Prevention

Lifestyle factors: exercise, sleep, hearing health, vascular health.

DEXA Bone Density

DEXA scan for bone + body composition — the trend matters more than a single value.

Epigenetic Clocks

Horvath, GrimAge, PhenoAge — what they measure and what they don't.

Epigenetics

DNA methylation, histone modifications, environmental influences on gene expression.

Exosomes

Cell-to-cell communication, regenerative applications, an early research field.

Genetic Tests

Variants, pharmacogenomics, limitations — methylation, MTHFR myths.

Glucosamine

Joints, UK Biobank mortality study, sulfate vs HCl forms.

Glycine

Methylation, collagen synthesis, lifespan signals in animal models.

Grip Strength

A strong mortality predictor — easy to measure, trainable.

Hallmarks of Aging

Genomic instability, telomere shortening, epigenetic alterations, and more.

Related topics from other worlds

Performance

Whey / Casein Protein

Amino acid profile, timing, and cow milk tolerance.

Recovery

CRP

C-reactive protein, hs-CRP as an inflammation marker, training's effect.

Recovery

Leucine

Anabolic amino acid, mTOR activator, the MPS threshold.

Recovery

PMR

The Jacobson technique — sensing and releasing bodily tension.

Recovery

Supercompensation

The load-recovery-adaptation cycle — the core principle of all training planning.

Sleep

Antihistamines

Diphenhydramine, doxylamine — sleep fragmentation, anticholinergic dementia risks.